Redeye comments on yesterday’s press release from Xspray that it has successfully scaled up its ASP formulation of its newly announced project XS015, an improved version of the active substance cabozantinib, extending its pipeline to four improved PKI products.

info@redeye.se (Redeye.se)

Redeye AB - Redeye.se